NUWE
Get informed when a big investor buys or sells
+ FollowOvervalued by 91.5% based on the discounted cash flow analysis.
| Market cap | $1.11 Million |
|---|---|
| Enterprise Value | $-710,543.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-25.39 |
| Beta | 0.3 |
| Outstanding Shares | 59,284 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.02 |
| Price to Book Ratio | 0.07 |
| Enterprise Value to Revenue | -0.08 |
| Enterprise Value to EBIT | 0.09 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.37 |
| Debt to Equity | 0.09 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 14.02%▲ 5.93% |
|---|---|
| Total Invested | $305,343▲ 34.42% |
| Investors Holding | 8▼ 2.00% |
No data
Nuwellis, Inc. , formally CHF Solutions, is a medical device company dedicated to changing the lives of patients suffering from fluid overload through science, collaboration, and innovation. The Company is focused on developing, manufact...